These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26021890)

  • 1. Targeted drug delivery in oncology: where drug discovery meets physics.
    Hooker BA; Blomme EA
    Vet J; 2015 Aug; 205(2):120-1. PubMed ID: 26021890
    [No Abstract]   [Full Text] [Related]  

  • 2. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E; Zhang C; Su Y; Cheng T; Shi C
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterinary oncology: Translating research advances into innovative therapeutic and diagnostic options.
    Blomme EA
    Vet J; 2015 Aug; 205(2):117-9. PubMed ID: 26095035
    [No Abstract]   [Full Text] [Related]  

  • 4. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
    Marblestone JG
    IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
    Pors K; Goldberg FW; Leamon CP; Rigby AC; Snyder SA; Falconer RA
    Drug Discov Today; 2009 Nov; 14(21-22):1045-50. PubMed ID: 19638319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10 Years CESAR Anticancer Drug Research - The 7th CESAR Annual Meeting 2009. Preface.
    Edler L; Sehrt D; Scheulen ME
    Int J Clin Pharmacol Ther; 2010 Jul; 48(7):435-9. PubMed ID: 20557836
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algeta and Ablynx collaborate to discover and develop targeted cancer therapies.
    King G
    Future Med Chem; 2013 Feb; 5(2):123. PubMed ID: 23476969
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanoparticle theories slowly turn into practice.
    Bender E
    Cancer Discov; 2011 Sep; 1(4):280. PubMed ID: 22586600
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug development in oncology assisted by noninvasive optical imaging.
    Sancey L; Dufort S; Josserand V; Keramidas M; Righini C; Rome C; Faure AC; Foillard S; Roux S; Boturyn D; Tillement O; Koenig A; Boutet J; Rizo P; Dumy P; Coll JL
    Int J Pharm; 2009 Sep; 379(2):309-16. PubMed ID: 19467306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncology drug discovery: planning a turnaround.
    Toniatti C; Jones P; Graham H; Pagliara B; Draetta G
    Cancer Discov; 2014 Apr; 4(4):397-404. PubMed ID: 24706659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discovery in neuro-oncology: challenges in the path forward.
    Levin VA
    Neuro Oncol; 2018 Mar; 20(4):435-436. PubMed ID: 29538691
    [No Abstract]   [Full Text] [Related]  

  • 13. Accelerating safe drug development: an ideal approach to approval.
    Grever MR
    Hematology Am Soc Hematol Educ Program; 2013; 2013():24-9. PubMed ID: 24319158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising targets and drugs in development for colorectal cancer.
    Thompson C; Leong S; Messersmith W
    Semin Oncol; 2011 Aug; 38(4):588-97. PubMed ID: 21810518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating cancer research by synthetic biology.
    Shankar S; Pillai MR
    Mol Biosyst; 2011 Jun; 7(6):1802-10. PubMed ID: 21437339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathologist and targeted therapies in oncology].
    Bertheau P
    Ann Pathol; 2009 Nov; 29 Spec No 1():S69-70. PubMed ID: 19887258
    [No Abstract]   [Full Text] [Related]  

  • 17. [Forefront of Cancer Targeting Therapy].
    Utoguchi N; Taira Y
    Yakugaku Zasshi; 2018; 138(7):901-902. PubMed ID: 29962466
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model.
    Lacko AG; Nair M; Paranjape S; Mooberry L; McConathy WJ
    Chemotherapy; 2006; 52(4):171-3. PubMed ID: 16691026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of predictive biomarkers in oncology drug development.
    Jørgensen JT
    Expert Rev Mol Diagn; 2016 Aug; 16(8):807-9. PubMed ID: 27282189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.